Screener
Capricor Therapeutics CAPR Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: Capricor Therapeutics’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-060382
| Line item | March 31, 2026 / (unaudited) | December 31, 2025 | December 31, 2025 |
|---|---|---|---|
| Deferred revenue, current | 12,000,000 | 12,000,000 | |
| TOTAL CURRENT LIABILITIES | 33,637,289 | 35,836,760 | |
| LONG-TERM LIABILITIES | |||
| Lease liabilities, net of current | 13,943,595 | 14,320,389 | |
| TOTAL LONG-TERM LIABILITIES | 13,943,595 | 14,320,389 | |
| TOTAL LIABILITIES | 47,580,884 | 50,157,149 | |
| COMMITMENTS AND CONTINGENCIES (NOTE 15) | |||
| STOCKHOLDERS’ EQUITY |
Item 1. Financial Statements.
FAQ
- What is Capricor Therapeutics's operating lease liabilities?
- Capricor Therapeutics (CAPR) reported operating lease liabilities of $13.94M in Q1 2026.
- How has Capricor Therapeutics's operating lease liabilities changed year-over-year?
- Capricor Therapeutics's operating lease liabilities increased by 3322.6% year-over-year, from $407.39K to $13.94M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about Capricor Therapeutics's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude